Deling Chen

Overview

Deling is an associate in Corporate/M&A department of Linklaters’ New York office. Deling has experience representing clients on a variety of cross-border corporate and capital markets transactions, including private and public mergers and acquisitions, joint ventures, corporate restructurings, entity formation and corporate governance, as well as investment grade bonds, high-yield bonds, median-term-note (MTN) programmes and GDRs.

Work Highlights

• Union Acquisition Corp. II: advising on its US$1.1 billion business combination with Crynssen Pharma Group Ltd.
• Bioceres Crop Solutions Corp.: advising on its acquisition of Marrone Bio Innovations, Inc., a NASDAQ-listed agricultural company, at a total value of approximately $236 million.
• Q-Energy Private Equity, SGEIC, SA: advising on its acquisition of Heelstone Renewable Energy, LLC, a U.S. utility-scale solar and storage develope, at a total enterprise value of US$375 million.
• Coöperatieve Rabobank U.A.: advising a consortium of banks as joint book-running managers on the issuance of US$1 billion 1.375% Fixed Rate Notes and US$450 million SOFR Floating Rate Notes under Rabobank’s New York Law 3(a)(2) MTN Program and a consortium of banks as joint lead managers on the issuance of US$1.25 billion 1.980% Fixed Rate Reset under Rabobank’s Dutch law Global Medium Term Note Program.
• Lepu Medical Technology: advising on a consortium of banks as joint book-running managers on Lepu’s GDR listing on the SIX Swiss Exchange via the China-Switzerland Stock Connect.
• Chindata Group Holdings Limited: advising on its debut issue of US$300 million 10.50% US dollar high yield notes due 2026, the first PRC high yield debut issuance in recent years.
• CLI Treasury Limited: advising a consortium of banks as joint lead managers on the issuance of S$425 million 4.20 per cent. Fixed Rate Senior Notes due 2030 by CLI Treasury Limited under its $6 billion Euro Medium Term Note Programme.

Beyond the Office

Deling has spent 15 months on his secondment in Capital Markets department of Linklaters’ Singapore and Hong Kong offices.